3 US Growth Stocks Riding AI And Critical Infrastructure Demand

With inflation signals mixed, central banks cautious and energy prices volatile, many investors are looking for stocks that can grow earnings while still keeping balance sheets in reasonable shape. That is exactly what the Healthy high growth potential screener focuses on. It highlights companies that analysts expect to grow earnings solidly over the next 3 years and that also meet basic financial health checks. In this article, you will see 3 stocks from this screener that stand out, along with a clear breakdown of why each one earns a spot on the list and what type of investor each may suit.

Kiniksa Pharmaceuticals International (KNSA)

Overview: Kiniksa Pharmaceuticals International is a biopharmaceutical company that develops and sells therapies for cardiovascular and inflammatory diseases, led by ARCALYST for recurrent pericarditis and cardiac sarcoidosis, and is advancing additional monoclonal antibody candidates such as KPL-387 and KPL-116. Founded in 2015 and now based in London, it operates across the US, the UK and other international markets.

Operations: Kiniksa generates its US$754.0m in revenue from developing and delivering therapeutic medicines.

Market Cap: US$5.0b

Kiniksa Pharmaceuticals International stands out in this screener because ARCALYST is already a commercial product in a niche cardiovascular disease with guideline support, and analysts see room for further earnings growth supported by a developing IL 1 pipeline. The company reports high payer coverage, strong treatment adherence and positive cash flow, while recent index inclusions and upward earnings estimate revisions have kept the stock in focus. At the same time, Kiniksa relies heavily on a single product, faces potential competition from new therapies and biosimilars, and is concentrated in the US market, which adds regulatory and reimbursement risk. For investors who can balance that trade off, the combination of current profitability, growth forecasts and deepening prescriber adoption may warrant further research.

Kiniksa Pharmaceuticals International already has a commercial foothold with ARCALYST, but the real story many investors may be missing sits in the analyst forecasts for Kiniksa Pharmaceuticals International, including a potential twist around its pipeline reliance.

USA Rare Earth (USAR)

Overview: USA Rare Earth is building a fully domestic mine to magnet supply chain for rare earth and other critical minerals, from its Round Top project in Texas through to processing and magnet production serving sectors like defense, electric vehicles, data centers and healthcare. Founded in 2019 and based in Oklahoma, the company is positioning itself as a potential key supplier for US and allied demand in technologies that depend on rare earth elements.

Market Cap: US$4.3b

USA Rare Earth is drawing attention because it sits at the intersection of national security priorities and the race to secure rare earth supplies, with government support that includes a planned 10% US Commerce Department stake, Department of Energy funding of up to US$19.3m for a pilot separations project, and state level grants for its Round Top project. At the same time, USAR is still loss making, has a cash runway of less than a year, and carries balance sheet and dilution risks, all overseen by a relatively new board and management team. For investors who can handle higher volatility and funding uncertainty, the company’s plans for an integrated US supply chain and expectations for faster revenue and earnings growth may encourage a closer look at how the thesis could develop over the next few years.

USA Rare Earth’s story sits at the intersection of national security demand and rare earth scarcity, yet funding and execution questions still hang over it, so the analyst forecasts for USA Rare Earth could reveal what the market is quietly pricing in

Advanced Energy Industries (AEIS)

Overview: Advanced Energy Industries provides precision power conversion, measurement and control systems that sit at the heart of semiconductor tools, AI data centers, industrial production lines and medical equipment, helping customers deliver stable, efficient power for demanding applications.

Operations: Advanced Energy Industries generates about US$1.9b in revenue, primarily from Power Electronics Conversion Products across its global customer base.

Market Cap: US$11.8b

Advanced Energy Industries appears in this screener because it is tied directly to two significant themes: AI data centers and advanced semiconductor manufacturing. The company is already generating profits with a 10.1% net margin and improving returns on equity. Analysts expect earnings to grow faster than revenue as higher margin products, factory efficiency and acquisitions take effect. Recent quarters have featured strong order books, product launches for high voltage AI architectures and positive broker coverage. On the other hand, there is meaningful reliance on a small group of hyperscale and chip equipment customers, exposure to tariffs and a balance sheet that depends on external borrowings. For investors who are comfortable with that concentration and funding risk, the combination of current forecasts, margin ambitions and AI linked demand may warrant a closer look at the company.

Advanced Energy Industries sits at the crossroads of AI demand and semiconductor tooling, yet many investors still treat it like a standard industrial. Walk through the analyst forecasts for Advanced Energy Industries to see what might be quietly shifting under the surface.

The three stocks here are only a starting point, and the full Healthy high growth potential screener has identified 248 more companies with equally compelling growth and financial health stories inside the Healthy high growth potential screener. Use Simply Wall St to identify and analyze the specific catalysts, earnings trends and balance sheet traits that matter most to you, so you can focus on the highest conviction ideas.

Take Control of Your Investment Journey

If USA Rare Earth or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

New breakouts and fresh momentum often get caught quickly, so under the radar for now opportunities can slip away before the crowd notices. Scan these ideas and consider them promptly.

• Target steady cash flow and resilient balance sheets by running through the curated list of solid balance sheet and fundamentals (47 results) before others spot their quiet momentum.
• Spot early compounding income potential as yields move and payout strength becomes more important, using the hand picked 9 dividend fortresses while it still flies under the radar.
• Follow the build out of critical infrastructure by reviewing the focused 34 power grid technology and infrastructure stocks before pricing fully reflects any momentum.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com